Showing 305–320 of 414 resultsSorted by popularity
P12 (without Adamax) is a modified ACTH(4-7) neurotrophic peptide blend that crosses the blood-brain barrier to upregulate BDNF transcription and activate TrkB survival signaling. A refined nootropic research tool for investigating neuroplasticity and cognitive enhancement.
Tesamorelin + Ipamorelin is a complementary GHRH/GHRP stack that combines a stabilized 44-amino acid GHRH analog with a selective ghrelin receptor agonist. Tesamorelin drives sustained visceral fat lipolysis while Ipamorelin amplifies GH pulsatility without ACTH or prolactin side effects.
Long-acting GLP-1 receptor agonist for appetite regulation and metabolic research. Investigate weight management pathways.
Cagri-Sema is a integrated dual-peptide blend of Cagrilintide and Semaglutide that simultaneously activates amylin/calcitonin and GLP-1 receptors for full-scale appetite suppression and glycemic control. This combination overcomes the receptor saturation plateau of GLP-1 monotherapy.
Insulin is a 51-amino-acid metabolic peptide hormone (MW ~5808 g/mol) that regulates glucose uptake and protein anabolism through PI3K/Akt signaling. Research applications include glucose transporter translocation studies and anabolic signaling pathway investigation. HPLC >99% purity.
HCG functions biologically almost identically to pituitary-derived luteinizing hormone (LH).
Adipotide FTPP is a targeted peptidomimetic that selectively binds prohibitin on white adipose vasculature, triggering mitochondrial apoptosis and eliminating fat tissue infrastructure. Unlike lipolytic agents that merely empty fat cells, Adipotide fundamentally destroys them.
Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist with a 39-amino acid structure and C20 fatty acid moiety for extended half-life. An oral formulation for investigating superior multi-incretin metabolic regulation and weight loss.
Telmisartan is a dual-action angiotensin II receptor blocker and partial PPAR-gamma agonist that simultaneously inhibits vasoconstriction and improves insulin sensitivity via GLUT4 upregulation. A unique research tool for metabolic and cardiovascular studies.
K-ATP channel opener for hair growth and vasodilation research. Study follicular stimulation mechanisms.
KPV (Lys-Pro-Val) is a C-terminal tripeptide fragment of alpha-MSH that modulates NF-kB signaling to suppress pro-inflammatory cytokine cascades. An oral formulation for investigating targeted anti-inflammatory pathways and mucosal tissue homeostasis.
Ivermectin is a macrocyclic lactone that potently agonizes glutamate-gated chloride channels in invertebrate nerve and muscle cells, inducing hyperpolarization and neuromuscular paralysis. An essential research tool for investigating antiparasitic mechanisms with an 18-hour half-life.
Type II 5-AR inhibitor for DHT suppression research. Study androgenetic alopecia and BPH pathways.
Dutasteride is a dual Type I and Type II 5-alpha-reductase inhibitor that reduces systemic DHT levels by over 90%, surpassing Finasteride’s single-isoenzyme selectivity. A thorough research tool for investigating maximal androgen blockade in DHT-sensitive tissues.
Enclomiphene (Androxal) is the purified trans-isomer of clomiphene that acts as a pure estrogen receptor antagonist at the pituitary, potently stimulating endogenous LH and FSH secretion without the mixed agonist properties of zuclomiphene. A go-to HPTA restoration research tool.
5-Amino-1MQ is a potent NNMT inhibitor that prevents nicotinamide methylation, diverting it into the NAD+ salvage pathway to elevate intracellular NAD+ and activate SIRT1. An oral formulation for investigating metabolic remodeling and adipose tissue reduction.
End of content
End of content
No products in the cart.
